Sympathetic tone assessed by washout of iodine 125-labeled metaiodobenzylguanidine from the murine left ventricle-influence of immobilization stress and inhibition of the renin-angiotensin system

[1]  I. Meredith,et al.  Cardiac Sympathetic Nervous Activit in Congestive Heart Failure Evidence for Increased Neuronal Norepinephrine Release and Preserved Neuronal Uptake , 1993, Circulation.

[2]  D. Ganten,et al.  Tissue renin-angiotensin systems. Their role in cardiovascular disease. , 1993, Circulation.

[3]  J. Cohn,et al.  Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention. , 1993, Circulation.

[4]  D. Fitchett,et al.  A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  B. Pitt,et al.  Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.

[6]  G. Sloman.  Angiotensin-converting enzyme inhibition, the sympathetic nervous system, and congestive heart failure , 1992 .

[7]  E. Botvinick,et al.  Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts--implications for clinical studies. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  P. Merlet,et al.  Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[10]  P. Timmermans,et al.  Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. , 1990, The Journal of pharmacology and experimental therapeutics.

[11]  M. Akers,et al.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. , 1988, Circulation.

[12]  B. Mock,et al.  Influence of specific activity on myocardial uptake of 123I‐mIBG in rats , 1988, Nuclear medicine communications.

[13]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[14]  J. Sisson,et al.  Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  J. Sisson,et al.  Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. , 1987, Cancer research.

[16]  M. Nakajo,et al.  Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  E. Sonnenblick,et al.  Pathophysiology of Heart Failure , 1985 .

[18]  K. Swedberg,et al.  Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. , 1984, The American journal of cardiology.

[19]  N. Clinthorne,et al.  Myocardial imaging with a radioiodinated norepinephrine storage analog. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  L. Kerwin,et al.  Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats. , 1980, European journal of pharmacology.

[21]  J. Cohn,et al.  Role of the Renin-Angiotensin System in the Systemic Vasoconstriction of Chronic Congestive Heart Failure , 1978, Circulation.

[22]  D. Paton.  The Mechanism of neuronal and extraneuronal transport of catecholamines , 1976 .

[23]  R. Wurtman,et al.  Norepinephrine Turnover in the Heart and Spleen of the Cardiomyopathic Syrian Hamster , 1975, Circulation research.

[24]  Khairallah Pa.  Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake. , 1972 .

[25]  R. Roth,et al.  Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation , 1971, British journal of pharmacology.